CFGS
ALT icon

Concourse Financial Group Securities’s Altimmune ALT Stock Holding History

Concourse Financial Group Securities’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100
Closed -$694 – 80
2024
Q4 		$694 Hold
100
– – ﹤0.01% 2125
2024
Q3 		$614 Hold
100
– – ﹤0.01% 2120
2024
Q2 		$665 Hold
100
– – ﹤0.01% 2173
2024
Q1 		$1.02K Hold
100
– – ﹤0.01% 2136
2023
Q4 		$1.13K Hold
100
– – ﹤0.01% 2098
2023
Q3 		$260 Hold
100
– – ﹤0.01% 2241
2023
Q2 		$353 Buy
+100
New +$449 ﹤0.01% 2251
2021
Q4 		– Sell
-200
Closed -$2.13K – 2363
2021
Q3 		$2K Hold
200
– – ﹤0.01% 2202
2021
Q2 		$2K Hold
200
– – ﹤0.01% 2163
2021
Q1 		$3K Buy
+200
New +$3.23K ﹤0.01% 2044

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Concourse Financial Group Securities's ALT Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Altimmune (ALT) in Q1 2025, closing a stake of 100 shares — an estimated $694 sold.

Concourse Financial Group Securities first reported a position in ALT in Q1 2021 and held it in 10 quarters. The position peaked at $3K in Q1 2021. 176 funds tracked by Wall St. Rank hold ALT as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Altimmune position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 100 Altimmune shares in Q1 2025, an estimated $694.
  • Concourse Financial Group Securities first reported a position in Altimmune in Q1 2021 and held it in 10 quarters.
  • Concourse Financial Group Securities's Altimmune position peaked at $3K in Q1 2021.
  • 176 funds tracked by Wall St. Rank held Altimmune as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.